Concord Biotech Ltd
NSE:CONCORDBIO
Cash Flow Statement
Cash Flow Statement
Concord Biotech Ltd
| Mar-2025 | Sep-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
4 946
|
4 291
|
|
| Depreciation & Amortization |
544
|
640
|
|
| Other Non-Cash Items |
(242)
|
(391)
|
|
| Cash Taxes Paid |
1 094
|
1 138
|
|
| Cash Interest Paid |
6
|
3
|
|
| Change in Working Capital |
(2 802)
|
(2 095)
|
|
| Cash from Operating Activities |
2 445
N/A
|
2 445
+0%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(1 112)
|
(1 149)
|
|
| Other Items |
(488)
|
(67)
|
|
| Cash from Investing Activities |
(1 600)
N/A
|
(1 216)
+24%
|
|
| Financing Cash Flow | |||
| Net Issuance of Debt |
(67)
|
(10)
|
|
| Cash Paid for Dividends |
(915)
|
(1 119)
|
|
| Other |
(5)
|
(1)
|
|
| Cash from Financing Activities |
(988)
N/A
|
(1 131)
-14%
|
|
| Change in Cash | |||
| Net Change in Cash |
(142)
N/A
|
99
N/A
|
|
| Free Cash Flow | |||
| Free Cash Flow |
1 333
N/A
|
1 297
-3%
|
|